These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21330105)

  • 1. Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer.
    Blanchard P; Hill C; Guihenneuc-Jouyaux C; Baey C; Bourhis J; Pignon JP;
    J Clin Epidemiol; 2011 Sep; 64(9):985-92. PubMed ID: 21330105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Network Meta-Analysis of the Systemic Therapies in Unresectable Head and Neck Squamous Cell Carcinoma.
    Yuan J; Shi K; Chen G; Xu W; Qiu L; Fei Y; Zhu Y; Wu M; Li Y; Sun X; Cao Y; Zhou S
    Cancer Control; 2024; 31():10732748241255535. PubMed ID: 38773761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
    Lacas B; Bourhis J; Overgaard J; Zhang Q; Grégoire V; Nankivell M; Zackrisson B; Szutkowski Z; Suwiński R; Poulsen M; O'Sullivan B; Corvò R; Laskar SG; Fallai C; Yamazaki H; Dobrowsky W; Cho KH; Beadle B; Langendijk JA; Viegas CMP; Hay J; Lotayef M; Parmar MKB; Aupérin A; van Herpen C; Maingon P; Trotti AM; Grau C; Pignon JP; Blanchard P;
    Lancet Oncol; 2017 Sep; 18(9):1221-1237. PubMed ID: 28757375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
    Chilimoniuk M; Olszewska E; Maksimowicz T
    Pol Merkur Lekarski; 2010 Dec; 29(174):357-60. PubMed ID: 21298984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction chemotherapy in head and neck cancer patients followed by concomitant docetaxel-based radiochemotherapy.
    Mencoboni M; Grillo-Ruggieri F; Salami A; Scasso F; Rebella L; Grimaldi A; Dellepiane M; Moratti G; Bruzzone A; Spigno F; Ghio R; Figliomeni M
    Eur J Cancer Care (Engl); 2011 Jul; 20(4):503-7. PubMed ID: 20477856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
    Petit C; Lacas B; Pignon JP; Le QT; Grégoire V; Grau C; Hackshaw A; Zackrisson B; Parmar MKB; Lee JW; Ghi MG; Sanguineti G; Temam S; Cheugoua-Zanetsie M; O'Sullivan B; Posner MR; Vokes EE; Cruz Hernandez JJ; Szutkowski Z; Lartigau E; Budach V; Suwiński R; Poulsen M; Kumar S; Ghosh Laskar S; Mazeron JJ; Jeremic B; Simes J; Zhong LP; Overgaard J; Fortpied C; Torres-Saavedra P; Bourhis J; Aupérin A; Blanchard P;
    Lancet Oncol; 2021 May; 22(5):727-736. PubMed ID: 33862002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysis.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Head Neck; 2015 May; 37(5):670-6. PubMed ID: 24596112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer.
    Gan HK; Bernstein LJ; Brown J; Ringash J; Vakilha M; Wang L; Goldstein D; Kim J; Hope A; O'Sullivan B; Waldron J; Abdul Razak AR; Chen EX; Siu LL
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):126-34. PubMed ID: 20708851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
    Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
    PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives].
    Blanchard P; Bourhis J; Lacas B; Le Teuff G; Michiels S; Pignon JP
    Cancer Radiother; 2015 May; 19(3):198-204; quiz 228-9, 233. PubMed ID: 25858708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.
    Jegannathen A; Mais K; Sykes A; Lee L; Yap B; Birzgalis A; Homer J; Ryder WD; Slevin N
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):149-58. PubMed ID: 20951012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum.
    Brizel DM; Esclamado R
    J Clin Oncol; 2006 Jun; 24(17):2612-7. PubMed ID: 16763273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
    Tao Y; Aupérin A; Graff P; Lapeyre M; Grégoire V; Maingon P; Geoffrois L; Verrelle P; Calais G; Gery B; Martin L; Alfonsi M; Deprez P; Bardet E; Pignon T; Rives M; Sire C; Bourhis J
    Oral Oncol; 2017 Aug; 71():61-66. PubMed ID: 28688693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetuximab in the treatment of squamous cell carcinoma of the head and neck.
    Specenier P; Vermorken JB
    Expert Rev Anticancer Ther; 2011 Apr; 11(4):511-24. PubMed ID: 21504318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.
    Clavel S; Fortin B; Després P; Donath D; Soulières D; Khaouam N; Charpentier D; Bélair M; Guertin L; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):763-9. PubMed ID: 20510546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network meta-analysis of the sequencing and types of systemic therapies with definitive radiotherapy in locally advanced squamous cell carcinoma of the head and neck (LASCCHN)☆.
    Jerzak KJ; Delos Santos K; Saluja R; Lien K; Lee J; Chan KKW
    Oral Oncol; 2017 Aug; 71():1-10. PubMed ID: 28688674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial.
    Rampino M; Ricardi U; Munoz F; Reali A; Barone C; Musu AR; Balcet V; Franco P; Grillo R; Bustreo S; Pecorari G; Cavalot A; Garzino Demo P; Ciuffreda L; Ragona R; Schena M
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):134-40. PubMed ID: 21030225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.